BALTIMORE (AP) — U.S. health regulators have approved the first blood test to help diagnose traumatic brain injuries.

The move means Banyan Biomarkers can commercialize its test, giving the San Diego-based company an edge in the biotech industry’s race to find a way to diagnose concussions.

The test doesn’t detect concussions, but instead measures two proteins present in brain cells. A blow to the head can cause the proteins to leak into the bloodstream. Banyan’s research shows the test can detect them up within 12 hours of injury. It’s designed to help doctors quickly determine which patients with suspected concussions may have brain bleeding or other brain injury.

The Food and Drug Administration approved the test Wednesday.

Follow @CBSBaltimore on Twitter and like WJZ-TV | CBS Baltimore on Facebook

(© Copyright 2018 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

Comments

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

More From CBS Baltimore

Track Weather On The Go With Our App!
CBS All Access
Download Our App

Watch & Listen LIVE